151 related articles for article (PubMed ID: 24901552)
1. Patent-free pact pushes the boundaries of precompetitive research.
Dolgin E
Nat Med; 2014 Jun; 20(6):564-5. PubMed ID: 24901552
[No Abstract] [Full Text] [Related]
2. The importance of patent sharing in neglected disease drug discovery.
Edlin C
Future Med Chem; 2011 Sep; 3(11):1331-4. PubMed ID: 21879838
[No Abstract] [Full Text] [Related]
3. Pharmacotherapy crisis in the spotlight--is open collaboration between academia and industry the answer?
Kaski JC
Cardiovasc Drugs Ther; 2011 Apr; 25(2):187-8. PubMed ID: 21503624
[No Abstract] [Full Text] [Related]
4. Precompetitive activity to address the biological data needs of drug discovery.
Sidders B; Brockel C; Gutteridge A; Harland L; Jansen PG; McEwen R; Michalovich D; Seidel H; Weiss B; Williams-Jones B; Woodwark M
Nat Rev Drug Discov; 2014 Feb; 13(2):83-4. PubMed ID: 24481293
[No Abstract] [Full Text] [Related]
5. How informatics can potentiate precompetitive open-source collaboration to jump-start drug discovery and development.
Perakslis ED; Van Dam J; Szalma S
Clin Pharmacol Ther; 2010 May; 87(5):614-6. PubMed ID: 20376001
[No Abstract] [Full Text] [Related]
6. Tropical disease: A neglected cause.
Laursen L
Nature; 2016 May; 533(7602):S68-9. PubMed ID: 27167396
[No Abstract] [Full Text] [Related]
7. Amendment to UK Patent Act provides further exception to patent infringement.
Sklan A
Pharm Pat Anal; 2014 Jul; 3(4):349. PubMed ID: 25291308
[No Abstract] [Full Text] [Related]
8. Competition: Unlikely partnerships.
Savage N
Nature; 2016 May; 533(7602):S56-8. PubMed ID: 27167391
[No Abstract] [Full Text] [Related]
9. Effectively managing an IP portfolio? Not an easy task.
Pontremoli G
Pharm Pat Anal; 2020 Jan; 9(1):7-8. PubMed ID: 32008443
[No Abstract] [Full Text] [Related]
10. Encouraging further innovation: Ariad v. Eli Lilly and the written description requirement.
Jakas J
Seton Hall Law Rev; 2012; 42(3):1287-36. PubMed ID: 22803220
[No Abstract] [Full Text] [Related]
11. Patent watch: EPO rejects reach through claims.
Nat Rev Drug Discov; 2010 Jan; 9(1):12. PubMed ID: 20043023
[No Abstract] [Full Text] [Related]
12. Science and the law. Working through the patent problem.
Walsh JP; Cohen WM; Arora A
Science; 2003 Feb; 299(5609):1021. PubMed ID: 12586928
[No Abstract] [Full Text] [Related]
13. Sources of innovation: an assessment of intellectual property.
Kinch MS; Raffo J
Drug Discov Today; 2015 May; 20(5):500-4. PubMed ID: 25499663
[TBL] [Abstract][Full Text] [Related]
14. Bilski blundering biotech.
Simmons WJ
Nat Biotechnol; 2009 Mar; 27(3):245-8. PubMed ID: 19270670
[No Abstract] [Full Text] [Related]
15. Canada's laws on pharmaceutical intellectual property: the case for fundamental reform.
Grootendorst P; Bouchard R; Hollis A
CMAJ; 2012 Mar; 184(5):543-9. PubMed ID: 22065362
[No Abstract] [Full Text] [Related]
16. The ELF Honest Data Broker: informatics enabling public-private collaboration in a precompetitive arena.
Paillard G; Cochrane P; Jones PS; van Hoorn WP; Caracoti A; van Vlijmen H; Pannifer AD
Drug Discov Today; 2016 Jan; 21(1):97-102. PubMed ID: 26608890
[TBL] [Abstract][Full Text] [Related]
17. Medicine. Can intellectual property save drug development?
FitzGerald GA
Science; 2012 Oct; 338(6106):483-4. PubMed ID: 23112323
[No Abstract] [Full Text] [Related]
18. Patent law protection of inventions in medicine and pharmaceutical industry.
Miladinović Z; Varga S; Radojković M
Vojnosanit Pregl; 2013 Jun; 70(6):600-5. PubMed ID: 23885528
[No Abstract] [Full Text] [Related]
19. Patent portfolios for biotech inventions.
Wang SJ
Nat Biotechnol; 2013 Jun; 31(6):501-3. PubMed ID: 23752433
[No Abstract] [Full Text] [Related]
20. Opening the lead generation toolbox.
Simpson PB; Reichman M
Nat Rev Drug Discov; 2014 Jan; 13(1):3-4. PubMed ID: 24378783
[No Abstract] [Full Text] [Related]
[Next] [New Search]
